NCT02363400: A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA |
|
|
| Enrolling by invitation | 3 | 147 | RoW | MEP, epirubicin, cisplatin, oral Tegafur-uracil, mitomycin-C | National Health Research Institutes, Taiwan, National Taiwan University Hospital, Mackay Memorial Hospital, China Medical University Hospital, National Cheng-Kung University Hospital, Kaohsiung Veterans General Hospital., Taichung Veterans General Hospital | Nasopharyngeal Carcinoma | 12/19 | 12/22 | | |
